Ovesco is part of the SEMECO initiative to develop smart medical devices

At Ovesco Endoscopy, we are passionate about advancing medical technology to improve patient outcomes and make innovative treatments more accessible. That is why we are proud to be part of SEMECO with out project about active intelligent capsule endoscopy.

What is SEMECO?

SEMECO, short for secure medical microsystems and communications, is an initiative to develop and approve smart medical devices and implants. It is one of the winners of the German Federal Ministry of Research, Technology and Space’s Clusters4Future competition. With up to €45 million in funding over nine years, SEMECO brings together leading minds from academia, industry, and clinical practice. The cluster is centered around TU Dresden and includes renowned partners such as the Else Kröner Fresenius Center for Digital Health, the 5G++Lab Germany, and the Barkhausen Institut.
More about SEMECO

Our project: intelligent capsule endoscopy

Our goal is to revolutionize capsule endoscopy by developing advanced features such as:

• Adaptive anchoring mechanisms for precise positioning within the gastrointestinal tract
• Tissue and liquid biopsy capabilities for comprehensive in-vivo diagnostics
• Real-time microbiome analysis using integrated gas sensors
• Controlled activation of mechanisms outside the body through bidirectional communication
• Magnetic capsule position control for targeted activation of diagnostic and therapeutic functions

Each year, around 6 million endoscopies are performed in Germany alone, playing a crucial role in diagnosing and treating gastrointestinal diseases, including cancer. Capsule endoscopes already offer a less invasive, more comfortable alternative to traditional procedures, especially for hard-to-reach areas like the small intestine. With the HemoPill® acute, an endoscopic capsule used to detect or exclude bleeding in the gastrointestinal tract, Ovesco has already demonstrated expertise in sensor capsules for endoscopy, which we are looking to expand further.

We look forward to continuing with this exciting project and initiative and improve medical care for patients worldwide.